新型冠状病毒灭活疫苗（Vero细胞）儿童及青少年I/II期临床试验

Project Title: Clinical Study of Phase I/II of SARS-CoV-2 Vaccine (Vero cell), Inactivated in Children and Adolescents

项目名称：新型冠状病毒灭活疫苗（Vero细胞）儿童及青少年I/II期临床试验

Data Sharing Statement

We support data sharing of the individual participant data. The individual participant-level data that underlie the results reported in this article will be shared after deidentification (text, tables, figures, and appendices). This clinical trial is ongoing, and all the individual participant data cannot be available until the immune persistence evaluation is conducted. The data will be available immediately after publication and finalisation of completed clinical study report for at least 6 months. Supporting clinical documents including the study protocol, statistical analysis plan and the informed consent form will be available immediately following the publication for at least 1 year. Supporting clinical documents access information will be available at the following link. Researchers who provide a scientifically sound proposal will be allowed to access to the de-identified individual participant data. Proposals should be directed to gaoq@sinovac.com or liqicdc226@163.com. These proposals will be reviewed and approved by the sponsor, investigators, and collaborators on the basis of scientific merit. To gain access, data requestors will need to sign a data access agreement.